Edition:
United States

Insider Trading: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

313.03USD
30 Sep 2016
Change (% chg)

$7.25 (+2.37%)
Prev Close
$305.78
Open
$306.59
Day's High
$314.38
Day's Low
$306.04
Volume
2,124,784
Avg. Vol
1,894,674
52-wk High
$333.65
52-wk Low
$223.02

All Insider Trades
Trading Date Name Title Type Shares Traded Price
21 Sep 2016

Dorsa (Caroline D)

Director Buy 2,570 $53.64
21 Sep 2016

Dorsa (Caroline D)

Director Buy 25,000 $53.64
21 Sep 2016

Dorsa (Caroline D)

Director Sell 27,570 $314.00
20 Jul 2016

Scangos (George A)

Chief Executive Officer Sell 157 $280.00
7 Jun 2016

Papadopoulos (Stelios B)

Director Buy 1,590 $0.00
7 Jun 2016

Pangia (Robert W)

Director Buy 1,060 $0.00
7 Jun 2016

Mulligan (Richard C)

Director Buy 1,060 $0.00
7 Jun 2016

Dorsa (Caroline D)

Director Buy 1,060 $0.00
7 Jun 2016

Posner (Brian S)

Director Buy 1,060 $0.00
7 Jun 2016

Sherwin (Stephen A)

Director Buy 1,060 $0.00
7 Jun 2016

Rowinsky (Eric K M.D.)

Director Buy 1,060 $0.00
7 Jun 2016

Schenk (Lynn A J.D.)

Director Buy 1,060 $0.00
7 Jun 2016

Leaming (Nancy L)

Director Buy 1,060 $0.00
7 Jun 2016

Denner (Alexander J)

Director Buy 1,060 $0.00
5 Jun 2016

Koppel (Adam)

Officer Sell 555 $290.00
2 Jun 2016

Scangos (George A)

Chief Executive Officer Sell 842 $290.00
1 Jun 2016

Koppel (Adam)

Officer Sell 534 $289.73
1 Jun 2016

Koppel (Adam)

Officer Buy 1,643 $0.00
31 May 2016

Scangos (George A)

Chief Executive Officer Sell 487 $287.97
31 May 2016

Ehlers (Michael D M.D., Ph.D.)

Officer Buy 3,034 $0.00
30 May 2016

Scangos (George A)

Chief Executive Officer Sell 3,368 $290.00
24 May 2016

Scangos (George A)

Chief Executive Officer Sell 157 $280.00
1 May 2016

Scangos (George A)

Chief Executive Officer Sell 487 $274.74
30 Apr 2016

Covino (Gregory F)

Officer Buy 348 $0.00
30 Apr 2016

Covino (Gregory F)

Officer Sell 113 $274.99

Institutional Holders

% Shares Owned: 88.52%
# of Holders: 1,364
Total Shares Held: 193,971,210
3 Mo. Net Change: -93,382
# New Positions: 117
# Closed Positions: 108
# Increased Positions: 577
# Reduced Positions: 551
# Net Buyers: 26

Officers & Directors

Name Age Since Current Position

Stelios Papadopoulos

67 2014 Independent Chairman of the Board

George Scangos

68 2010 Chief Executive Officer, Director

Paul Clancy

54 2007 Chief Financial Officer, Executive Vice President - Finance

Kenneth Di Pietro

57 2012 Executive Vice President - Human Resources

Susan Alexander

59 2011 Executive Vice President, Chief Legal Officer and Corporate Secretary

Michael Ehlers

2016 Executive Vice President of Research and Development

Steven Holtzman

62 2011 Executive Vice President - Corporate Development

Adriana Karaboutis

53 2014 Executive Vice President - Technology , Business Solutions and Corporate Affairs

Adam Koppel

46 2015 Executive Vice President - Strategy and Business Development

Paul McKenzie

2016 Executive Vice President - Pharmaceutical Operations & Technology

Alfred Sandrock

58 2015 Executive Vice President - Neurology Discovery and Development and Chief Medical Officer

Spyros Artavanis-Tsakonas

69 2013 Senior Vice President, Chief Scientific Officer

Gregory Covino

50 2012 Chief Accounting Officer, Vice President - Finance

Michel Vounatsos

2016 Vice President and Chief Commercial Officer

Alexander Denner

46 2009 Independent Director

Caroline Dorsa

56 2010 Independent Director

Nancy Leaming

68 2008 Independent Director

Richard Mulligan

61 2009 Independent Director

Robert Pangia

65 1997 Independent Director

Brian Posner

54 2008 Independent Director

Eric Rowinsky

59 2010 Independent Director

Lynn Schenk

71 1995 Independent Director

Stephen Sherwin

67 2010 Independent Director